UCB Market Share Analysis for June 2026

Form | UCB

Health > Biotechnology and Pharmaceuticals

Domainucb-usa.com

Year Founded1928

Employees5001 - 10000

Annual Revenue> $1B

UCB

UCB (including company regionals)

ucb-usa.com

See more website traffic and engagement information

UCB Revenue up to June 2026 is > 1B

revenue generated by UCB top domains

UCB top domains revenue over 3 years

Revenue for UCB top domains

ucb-usa.com> 1B

See more with Sales Intelligence

UCB Stock price in June 2026

UCB stock is traded under the ticker #UCBJF. Below you can review UCB stock performance in the past 12 months up to June 2026

Total visits to UCB's top domains

Understand UCB market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ucb-usa.com28.5K

See more with Sales Intelligence

Avg. visit duration in UCB's top domains

Analyze UCB engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ucb-usa.com00:01:04

See more with Sales Intelligence

Avg. pageviews on UCB's top domains

See how UCB keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ucb-usa.com1.90

See more with Sales Intelligence

UCB top competitors by domain

Top similar sites in June 2026, ranked by their affinity

aurobindo.comCompany NameAurobindo PharmaEmployees> 10001HQIndia, HyderabadAnnual revenue$25M - $50MTotal visits37.5KHealth > Health - Other

Top technologies used by UCB

These are the website technologies, by industry, used by UCB top domains

Advertising (9)

DoubleClick

Social (6)

Instagram

Conversion & Analytics (5)

Google Analytics

Audio Video Media (4)

YouTube

More Technologies

8

See all

News & Signals from UCB

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsUCB, Inc expanded facilities to Georgia, Western Asia, Asia on Mar 25th '26.Governor Brian P. Kemp today announced that global biopharmaceutical giant UCB, Inc. is planning a significant investment of $2 billion in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility.

NewsUCB, Inc invests into assets: biopharma plant in the amount of $2B in Georgia, Western Asia, Asia.UCB inc. to spend $2 billion on new Georgia biopharma plant.

NewsUCB, Inc invested into assets: U.S. Manufacturing facility in the amount of $2B in Georgia, Western Asia, Asia on Mar 24th '26.UCB to invest $2 billion in Georgia, establish first U.S. Manufacturing facility.